I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 9 studies | 20% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 20% ± 4% | |
| endothelial cell | 5 studies | 22% ± 8% | |
| epithelial cell | 5 studies | 34% ± 15% | |
| erythrocyte | 5 studies | 44% ± 15% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 2% | |
| erythroblast | 4 studies | 45% ± 25% | |
| astrocyte | 4 studies | 23% ± 3% | |
| glutamatergic neuron | 4 studies | 40% ± 21% | |
| oligodendrocyte | 4 studies | 21% ± 2% | |
| hematopoietic precursor cell | 3 studies | 30% ± 9% | |
| conventional dendritic cell | 3 studies | 27% ± 9% | |
| non-classical monocyte | 3 studies | 23% ± 7% | |
| retinal ganglion cell | 3 studies | 53% ± 26% | |
| amacrine cell | 3 studies | 33% ± 12% | |
| retina horizontal cell | 3 studies | 28% ± 13% | |
| fibroblast | 3 studies | 24% ± 7% | |
| ciliated cell | 3 studies | 21% ± 4% | |
| GABAergic neuron | 3 studies | 37% ± 15% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 35% ± 23% | |
| basal cell | 3 studies | 29% ± 9% | |
| interneuron | 3 studies | 30% ± 14% | |
| oligodendrocyte precursor cell | 3 studies | 22% ± 4% |
